- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
6976
TWO
Week ended 14 Aug 2026
Weekly Investor Report
Acepodia, Inc. · Healthcare · Biotechnology
Latest close
11.70 TWD
-2.1%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -8.7% below the Trend Line and sits at 10.2% of its 52-week range. The latest completed week returned -2.1%, after a -10.3% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
16
out of 100
Latest Close
11.70 TWD
14 Aug 2026
1W Return
-2.1%
latest completed week
4W Return
-10.3%
short-term follow-through
12W Return
-12.0%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.1%
Latest completed week; four-week move -10.3%.
Indicator stack
0/36
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 33.93%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -8.7% below the Trend Line and sits at 10.2% of its 52-week range. The latest completed week returned -2.1%, after a -10.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0612-week average 0.07
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals2Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -10.3% over four weeks, -12.0% over 12 weeks, and -23.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.21Latest activity-pressure read.
Pressure change-126.1%Four-week change in activity pressure.
Leadership-42.73Latest relative-leadership reading.
RS change-20.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-38.9%Distance below the 52-week high.
13-week volatility3.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher8 of 2617 weeks finished lower.
Best week+10.0%Week of 3 Apr.
Worst week-8.3%Week of 29 May.
Latest week-2.1%Week of 14 Aug.
Shape of recent returns
Strong gains2
Modest gains6
Flat weeks1
Modest losses13
Sharp losses4
Recent vol3.7%13-week weekly-return volatility.
Base vol4.1%52-week weekly-return volatility.
Up/down split18/32Count of positive and negative weeks in the 52-week window.
Average skew3.7% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank92 / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank85 / 96
Group average-2.7%
Trend breadth24.0%
Trend24.0%active weekly trend signals
MD39.6%positive activity pressure
RS6.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape16/100
Trend, activity pressure, participation, and risk combine to a 16/100 tape read.
Indicator analysis29/100Latest 12-week confirmation: trend 0/12, activity pressure 11/12, relative leadership 0/12.
Activity pressure 0.06; No reversal markers Next-Week ExpectancyNegative 33.93%Next-week expectancy is negative with a 33.93% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 11.70 TWD | -2.1% | 12.82 TWD | 21.20 TWD | -0.21 | -42.73 | 1.8M | Off |
| 7 Aug 2026 | 11.95 TWD | -0.8% | 12.93 TWD | 21.26 TWD | 0.11 | -40.39 | 2.2M | Off |
| 31 Jul 2026 | 12.05 TWD | -3.6% | 13.05 TWD | 21.32 TWD | 0.41 | -39.29 | 1.7M | Off |
| 24 Jul 2026 | 12.50 TWD | -4.2% | 13.16 TWD | 21.38 TWD | 0.67 | -38.80 | 2.0M | Off |
| 17 Jul 2026 | 13.05 TWD | -1.5% | 13.27 TWD | 21.44 TWD | 0.80 | -35.58 | 1.6M | Off |
| 10 Jul 2026 | 13.25 TWD | 0.0% | 13.36 TWD | 21.49 TWD | 0.69 | -39.34 | 3.2M | Off |
| 3 Jul 2026 | 13.25 TWD | 1.9% | 13.41 TWD | 21.55 TWD | 0.60 | -42.16 | 2.7M | Off |
| 26 Jun 2026 | 13.00 TWD | 7.4% | 13.46 TWD | 21.60 TWD | 0.51 | -41.46 | 5.4M | Off |
| 19 Jun 2026 | 12.10 TWD | -2.0% | 13.51 TWD | 21.66 TWD | 0.39 | -48.67 | 1.5M | Off |
| 12 Jun 2026 | 12.35 TWD | -1.6% | 13.62 TWD | 21.73 TWD | 0.55 | -45.97 | 3.3M | Off |
| 5 Jun 2026 | 12.55 TWD | 2.9% | 13.71 TWD | 21.79 TWD | 0.60 | -47.27 | 3.1M | Off |
| 29 May 2026 | 12.20 TWD | -8.3% | 13.83 TWD | 21.85 TWD | 0.51 | -49.39 | 5.1M | Off |
| 22 May 2026 | 13.30 TWD | 2.3% | 13.97 TWD | 21.92 TWD | 0.40 | -42.77 | 6.4M | Off |
| 15 May 2026 | 13.00 TWD | 2.8% | 14.07 TWD | 21.98 TWD | 0.04 | -43.64 | 5.9M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.